Novavax Inc (NVAX)
4.475
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
4.49
+0.02
(+0.34%)
After-Hours: 16:46
Novavax Accounts Receivable (Quarterly): 297.24M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 297.24M |
September 30, 2023 | 123.66M |
June 30, 2023 | 394.89M |
March 31, 2023 | 112.85M |
December 31, 2022 | 82.38M |
September 30, 2022 | 111.64M |
June 30, 2022 | 194.53M |
March 31, 2022 | 478.16M |
December 31, 2021 | 454.99M |
September 30, 2021 | 75.28M |
June 30, 2021 | 49.99M |
March 31, 2021 | 56.90M |
December 31, 2020 | 262.01M |
September 30, 2020 | 12.36M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 7.50M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 0.591M |
June 30, 2016 | 0.363M |
March 31, 2016 | 0.406M |
December 31, 2015 | 2.32M |
September 30, 2015 | 2.197M |
June 30, 2015 | 2.342M |
March 31, 2015 | 6.674M |
December 31, 2014 | 7.51M |
September 30, 2014 | 2.859M |
June 30, 2014 | 3.719M |
March 31, 2014 | 4.466M |
December 31, 2013 | 1.911M |
September 30, 2013 | 1.911M |
June 30, 2013 | 0.907M |
March 31, 2013 | 2.602M |
December 31, 2012 | 1.011M |
September 30, 2012 | 2.469M |
June 30, 2012 | 1.498M |
March 31, 2012 | 1.725M |
December 31, 2011 | 1.965M |
September 30, 2011 | 0.017M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
478.16M
Maximum
Mar 2022
159.67M
Average
111.64M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
Pfizer Inc | 10.99B |
Moderna Inc | 137.00M |
Agilent Technologies Inc | 1.295B |
Halozyme Therapeutics Inc | 233.25M |
Vaxart Inc | 3.008M |